Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Rubicon ResearchNSE:RUBICON +1.45%18 Days Inventory is 392.90 as of Mar. 2026, which is 3% below its 10-year median of 405.06. GuruFocus rates NSE:RUBICON with a GF Score™ of 18/100. The stock has 3 warning signs investors should review. Among 922 Drug Manufacturers companies, Rubicon Research ranks worse than 95.23% on this metric.
The historical rank and industry rank for Rubicon Research's Days Inventory or its related term are showing as below:
NSE:RUBICON'
s Days Inventory Range Over the Past 10 Years
Min: 290.06 Med: 405.06 Max: 510.27
Current: 510.27
During the past 4 years, Rubicon Research's highest Days Inventory was 510.27. The lowest was 290.06. And the median was 405.06.
NSE:RUBICON's Days Inventory is ranked worse than 95.23% of 922
companies
in the Drug Manufacturers industry
Industry Median: 164.58
vs NSE:RUBICON: 510.27
Rubicon Research's Days Inventory
increased
from Dec. 2024 (0.00) to Mar. 2026 (392.90).
It might indicate that Rubicon Research's sales slowed down.
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Rubicon Research's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.23.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Rubicon Research's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 1.42.
Rubicon Research (NSE:RUBICON) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Rubicon Research's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Rubicon Research's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Rubicon Research Days Inventory Related Terms
Rubicon Research Days Inventory Historical Data
* Premium members only.
The historical data trend for Rubicon Research's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:RUBICON vs LLY, JNJ, ABBV: Days Inventory Comparison
For the Drug Manufacturers - General subindustry, Rubicon Research's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rubicon Research Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Rubicon Research's Days Inventory distribution charts can be found below:
* The bar in red indicates where Rubicon Research's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rubicon Research (NSE:RUBICON) has a Days Inventory of 392.90 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Rubicon Research and its competitors. This is near median its historical median of 405.06. Over the past decade, Rubicon Research's Days Inventory has ranged from 290.06 to 510.27. According to the industry distribution chart, Rubicon Research ranks #878 out of 922 companies in the Drug Manufacturers industry, placing it in the top 95.2%.
Is Rubicon Research's Days Inventory too high?
Rubicon Research's current Days Inventory of 392.90 is near median its 10-year median of 405.06. Over the past 10 years, this metric has ranged from a low of 290.06 to a high of 510.27. The Drug Manufacturers industry median Days Inventory is 164.58. Rubicon Research's value of 392.90 is 138.7% above this industry median. Based on the distribution chart, Rubicon Research ranks #878 out of 922 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Rubicon Research has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Rubicon Research's Days Inventory compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Rubicon Research ranks #878 out of 922 companies for Days Inventory. This places Rubicon Research in the lower half of its industry. The industry median Days Inventory is 164.58. Rubicon Research's value of 392.90 is 138.7% above this benchmark. Historically, Rubicon Research's own Days Inventory has ranged from 290.06 to 510.27 over the past decade. While the company's 10-year median is 405.06 vs. the industry median of 164.58, Rubicon Research has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.58, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rubicon Research's current Days Inventory of 392.90 is 138.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Rubicon Research and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rubicon Research's current Days Inventory is 392.90, which is near median its own 10-year median of 405.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rubicon Research stock overvalued right now?
Rubicon Research (NSE:RUBICON) has a current Days Inventory of 392.90. The current Days Inventory is 392.90, which is near median its 10-year median of 405.06 and 138.7% above the Drug Manufacturers industry median of 164.58. Rubicon Research's overall GF Score™ is 18/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Rubicon Research (NSE:RUBICON), the current Days Inventory is 392.90 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Rubicon Research Ltd is a pharmaceutical formulations company specializing in developing, manufacturing, and marketing branded specialty and generic prescription products. Starting as a provider of contract formulation development services, the company expanded to operate an oral solids manufacturing facility in India, offering contract development and manufacturing services for regulated markets. The company's diverse product portfolio covers multiple therapeutic areas, including analgesics and pain management, CVS, CNS, hypokalemia, skeletal muscle relaxants, NRT, gastrointestinal, metabolic, and immunosuppressants. The company operates in India, the USA, and other markets, with the majority of its revenue coming from the USA.
18GF Score
Get the complete analysis for NSE:RUBICON
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:RUBICON has been successfully added to your 
